Plasma-Lyte is a crystalloid solution for

intravenous infusion Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients directly into a person's vein. The intravenous route of administration is commonly used for rehydration or to provide nutrie ...

, with varying

electrolyte An electrolyte is a medium containing ions that is electrically conducting through the movement of those ions, but not conducting electrons. This includes most soluble salts, acids, and bases dissolved in a polar solvent, such as water. Upon dis ...

formulation depending on market. Generally the solution has a composition that mimics human physiological plasma electrolyte concentrations, osmolality and pH. It is available as a

generic medication A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active ch ...

. __TOC__

Plasma-lyte 148 (pH7.4)

Plasma-Lyte 148 is a market-specific solution available in the United Kingdom and Australia, among others and has the following composition: Sodium 140 mmol/L
Potassium 5 mmol/L
Magnesium 1.5 mmol/L
Chloride 98 mmol/L
Acetate 27 mmol/L
Gluconate 23 mmol/L This solution is manufactured and marketed by

Baxter International Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company ...

Inc.2: Baxter. Plasma-Lyte 148 product information. 2013. available at URL: http://www.baxterhealthcare.com.au/downloads/healthcare_professionals/cmi_pi/plasmalyte148_pi.pdf

References

{{Reflist Blood substitutes Intravenous fluids